Latest news with #Enfamil
Malaysian Reserve
3 days ago
- Business
- Malaysian Reserve
RBGLY Investors Have Opportunity to Lead Reckitt Benckiser Group PLC Securities Fraud Lawsuit
NEW YORK, June 7, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of American Depositary Shares ('ADSs') of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 through July 28, 2024, both dates inclusive (the 'Class Period'). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 4, 2025. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. So What: If you purchased Reckitt ADSs you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the Reckitt class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@ for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 4, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, during the Class Period, defendants failed to warn investors and consumers: (1) that preterm infants were at an increased risk of developing necrotizing enterocolitis ('NEC') by consuming Reckitt's cow's milk-based formula, Enfamil; (2) of the attendant impact on Reckitt's sales of Enfamil and Reckitt's exposure to legal claims; and (3) as a result of the above, defendants' positive statements about Reckitt's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Reckitt action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@ for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@
Yahoo
4 days ago
- Business
- Yahoo
Some Zeeland neighbors want to block Mead Johnson expansion
ZEELAND, Mich. (WOOD) — While some property owners have gotten more than $1 million from Mead Johnson for land that the company needs to expand on East Main Street, Margie and Earl Klein aren't selling. Some neighbors say they hope the holdouts will help block the expansion, which they fear will destroy their neighborhood. The Kleins have lived since 1973 in their home about 150 yards west of the baby formula plant — at the heart of the company's controversial expansion plans. They raised two kids there. Her parents lived there in the 1920s. 'We still walk on the hardwood floors that my parents did,' Margie Klein said on Friday. In January, she answered a knock on her door. It was a stranger from Mead Johnson. 'He sat down on our couch and said, 'We want your property.' 'Really?' 'And all of this on both sides of you, and we want everything on Washington Avenue, also,'' she recalled. Mead Johnson, now owned by a United Kingdom-based company, says it needs to modernize. Its $836 million plan calls for an expansion that would mean leveling several homes on the north side of East Main Street, including the Kleins'. The company, which makes Enfamil, released renderings at a meeting this week. The plan requires the city to rezone some of the land from residential to industrial. A hearing is scheduled before the city's Planning Commission Thursday. The company is the third-biggest taxpayer in Zeeland and employs 500 people. 'Mead Johnson Nutrition takes pride in our deep roots in the Zeeland community where we have been producing some of the nation's most trusted baby formula products for more than 100 years,' the company said in a statement released on Friday. 'This investment in modernizing our operations in Zeeland reflects our commitment to sustained job creation and economic growth here in our local community, while also ensuring we maintain industry-leading quality standards and remain a trusted partner in pediatric nutrition.' 'Mead Johnson is important to the community, we want to keep them here,' City Manager Timothy Klunder said. 'We certainly don't want to see a desire where they would have to leave, but we also want then to do it in the right way.' Neighbors have planted signs and launched a website in opposition. Already, the company has bought out most of the Kleins' closest neighbors: One said he sold his home for $600,000 and must be out by July 31. Property records show the company paid $1.5 million for a house and barn a few doors away with an assessed value of less than $300,000. Two properties around the corner went for a combined $3.7 million — about 10 times their assessed value. The Kleins won't say exactly how much Mead Johnson has offered. It's somewhere between $500,000 and $1 million. 'We love our place, but we don't want to sell to Mead Johnson because they are pushy and demanding,' Klein said. Asked if she was holding out for more money, she responded: 'Oh heavens, no.' 'This has nothing to do with the money,' she continued. 'It's the whole principle of the thing. We have lived here for decades. We are so involved in the city of Zeeland, chamber of commerce back in the day. We love this town.' Jonathan Funckes lives on the south side of East Main Street. His home would face the expanded factory. 'I'll be looking at Industrial 2 (zoning),' he said. 'When we bought this, this was all residential.' When Funckes moved in 16 years ago, he said, the neighborhood was mostly rentals, some marred by graffiti. 'We've all in the last dozen years really improved it and brought the neighborhood up and are doing things to improve and make it look better, only to have the city just destroy our property values,' he said. Some neighbors said they fear city leaders have already decided. 'Why would you purchase these (properties) way above tax-assessed values if you didn't have some sort of promise?' Sue VandenBeldt, who lives a few doors away. 'My concern is that the city has sold our neighborhood out. I think my big concern is that we've lost trust in our officials we elected.' As for Jonathan Funckes, 'We're going to be fighting it, but at this point I'm preparing to sell, because I've had enough.' Perhaps, he said, the best hope is the Kleins not selling. 'That's the only saving grace at this point,' he said. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Business Wire
4 days ago
- Business
- Business Wire
RBGLY Investors Have Opportunity to Lead Reckitt Benckiser Group plc Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Reckitt Benckiser Group plc ('Reckitt' or 'the Company') (OTC: RBGLY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 13, 2021 and July 28, 2024, inclusive (the 'Class Period'), are encouraged to contact the firm before August 4, 2025. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. Reckitt failed to inform investors that preterm infants suffered an increased risk of developing necrotizing enterocolitis ('NEC') when consumed its Enfamil formula. The Company misled investors about its exposure to legal claims related to NEC. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Reckitt, investors suffered damages. Join the case to recover your losses. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Business Wire
4 days ago
- Business
- Business Wire
Rosen Law Firm Urges Reckitt Benckiser Group PLC (OTC: RBGLY) Stockholders to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of American Depositary Shares ('ADSs') of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 through July 28, 2024. Reckitt describes itself as a 'U.K.-based consumer goods and health conglomerate.' For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Reckitt Benckiser Group PLC (OTC: RBGLY) Misled Investors Regarding its Business Operations. According to the lawsuit, during the Class Period, defendants failed to warn investors and consumers: (1) that preterm infants were at an increased risk of developing necrotizing enterocolitis ('NEC') by consuming Reckitt's cow's milk-based formula, Enfamil; (2) of the attendant impact on Reckitt's sales of Enfamil and Reckitt's exposure to legal claims; and (3) as a result of the above, defendants' positive statements about Reckitt's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. What Now: You may be eligible to participate in the class action against Reckitt Benckiser Group PLC. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by August 4, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders. Attorney Advertising. Prior results do not guarantee a similar outcome.
Business Wire
5 days ago
- Business
- Business Wire
RECKITT BENCKISER SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Reckitt Benckiser Group PLC
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)-- Kahn Swick & Foti, LLC ('KSF') and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until to file lead plaintiff applications in a securities class action lawsuit against Reckitt Benckiser Group PLC ('Reckitt' or the 'Company') (OTC: RBGLY), if they purchased the Company's American Depositary Shares ('ADSs') between January 13, 2021 and July 28, 2024, inclusive (the 'Class Period'). This action is pending in the United States District Court for the Southern District of New York. What You May Do If you purchased ADSs of Reckitt and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ( or visit to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by August 4, 2025. About the Lawsuit Reckitt and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. The alleged false and misleading statements and omissions include, but are not limited to, that: (i) preterm infants were at an increased risk of developing necrotizing enterocolitis ('NEC') by consuming the Company's cow's milk-based formula, Enfamil; (ii) such risk could impact the Company's sales of Enfamil and expose the Company to legal claims; and (iii) as a result of the foregoing, the Company's positive statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. The case is Elevator Constructors Union Local No. 1 Annuity & 401(K) Fund v. Reckitt Benckiser Group PLC, et al., No. 25-cv-4708. About Kahn Swick & Foti, LLC KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg. TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services To learn more about KSF, you may visit
